Impairment of skin barrier function via cholinergic signal transduction in a dextran sulphate sodium-induced colitis mouse model

Skin disruption is associated with indomethacin-induced small intestinal injury in mice

(2014) Satoshi Yokoyama et al.   EXPERIMENTAL DERMATOLOGY

The Enzyme Cyp26b1 Mediates Inhibition of Mast Cell Activation by Fibroblasts to Maintain Skin-Barrier Homeostasis

(2014) Yosuke Kurashima et al.   IMMUNITY

Mast cell activity in the healing wound: more than meets the eye?

(2013) Brian C. Wulff et al.   EXPERIMENTAL DERMATOLOGY

iNOS-Dependent Increase in Colonic Mucus Thickness in DSS-Colitic Rats

(2013) Olof Schreiber et al.   PLoS One

Stem Cell Factor Programs the Mast Cell Activation Phenotype

(2012) T. Ito et al.   JOURNAL OF IMMUNOLOGY

Venous Thromboembolism in Inflammatory Bowel Disease: An Epidemiological Review

(2011) Sanjay K Murthy et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Expression of muscarinic receptors by human macrophages

(2011) A. Koarai et al.   EUROPEAN RESPIRATORY JOURNAL

Inducible nitric oxide synthase (iNOS) and α-melanocyte-stimulating hormones of iNOS origin play important roles in the allergic reactions of atopic dermatitis in mice

(2011) Kumi Orita et al.   EXPERIMENTAL DERMATOLOGY

The cholinergic system in guttate psoriasis with special reference to mast cells

(2011) Julia Radosa et al.   EXPERIMENTAL DERMATOLOGY

Cellobiose Prevents the Development of Dextran Sulfate Sodium (DSS)-Induced Experimental Colitis

(2010) Takashi Nishimura et al.   JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION

Cutaneous signs of liver disease: value for prognosis of severe fibrosis and cirrhosis

(2010) Claus Niederau et al.   LIVER INTERNATIONAL

Targeting CD44 in mast cell regulation

(2009) Satoshi Tanaka   EXPERT OPINION ON THERAPEUTIC TARGETS